The Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos (Institute of Technology in Immunobiology Bio-Manguinhos) has just started the bidding process for its $127 million project for fill and finish production of Oxford's COVID-19 vaccine. The vaccine is still in the clinical human trials stage, but conclusive results are expected before the end of the year.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
